Platelet Function and the Bleeding Time in Progressive Renal Failure

Summary

Bleeding time and platelet function tests were performed on 31 patients with progressive chronic renal failure (CRF) due to non-immunological (urological) causes, and compared with 22 healthy controls. Patients were classified as mild (plasma creatinine <300 μmol/l), moderate (300-600 μmol/l) or severe renal failure (>600 μmol/l). Bleeding time was rarely prolonged in mild and moderate CRF and mean bleeding time significantly elevated only in severe CRF (p <0.005). Haematocrit was the only index which correlated with bleeding time (r = -0.40). Platelet counts, collagen stimulated thromboxane generation, and platelet aggregation responses to ADP, collagen and ristocetin were all either normal or increased in all three CRF groups, but thromboxane production in clotting blood was reduced. Plasma fibrinogen, C reactive protein and von Willebrand factor (vWF) were elevated in proportion to CRF. We found no evidence that defects in platelet aggregation or platelet interaction with vWF prolong the bleeding time in patients with progressive CRF.

Key words

Platelets - Bleeding time - Renal failure

• References

• 1 Steiner RW, Coggins C, Carvalho ACA. Bleeding time in uraemia: a useful test to assess clinical bleeding. Am J Hematol 1979; 7: 107-117
• 2 Di Minno G, Martinez J, McKean M, De La Rosa J, Burke JF, Murphy S. Platelet dysfunction in uraemia. Multifaceted defect partially corrected by dialysis. Am J Med 1985; 79: 552-559
• 3 Remuzzi G, Benigni A, Dodesini P, Schieppati A, Livio M, De Gaetano G, Day JS, Smith WL, Pinea E, Patrignani P, Patrono C. Reduced platelet thromboxane formation in uraemia. Evidence for a functional cyclooxygenase defect. J Clin Invest 1983; 71: 762-768
• 4 Turney JH, Woods HF, Fewell MR, Weston MJ. Factor VIII complex in uraemia and the effects of haemodialysis. Br Med J 1981; 282: 1653-1656
• 5 Veiner A, Aviram M, Better OS, Brook JG. Enhanced in vitro platelet aggregation in haemodialysis patients. Nephron 1986; 43: 139-143
• 6 Bloom A, Greaves M, Preston FE, Brown CB. Evidence against a platelet cyclooxygenase defect in uraemic subjects on chronic haemodialysis. Br J Haematol 1986; 62: 143-149
• 7 Rylance PB, Gordge MP, Weston MJ. Platelet function is enhanced, not reduced in uraemia. Proc Eur Dial Transplant Assoc 1985; 22: 946-952
• 8 Remuzzi G, Marchesi D, Cavenaghi AE, Livio M, Donati MB, De Gaetano G, Mecca G. Bleeding in renal failure: a possible role of vascular prostacyclin (PGI₂). Clin Nephrol 1979; 12: 127-131
• 9 Castillo R, Lozano T, Escolar G, Revert L, Lopez J, Ordinas A. Defective platelet adhesion on vessel subendothelium in uraemic patients. Blood 1986; 68: 337-342
• 10 Fernandez F, Goudable C, Sie P, Ton-That H, Durand D, Suc JM, Boneu B. Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusion. Br J Haematol 1985; 59: 139-148
• 11 Rylance PB, Gordge MP, Weston MJ. Correction of citrate concentration is necessary in platelet aggregometry studies in uraemia. Clin Nephrol 1985; 23: 155-156
• 12 Kelton JG, Powers P, Julian J, Boland V, Carter C, Gent M, Hirsh J. Sex-related differences in platelet aggregation: influence of the haematocrit. Blood 1980; 56: 38-41
• 13 Carter AJ, Hanley SR. The effect of platelet number and haematocrit on whole blood thromboxane synthesis. Thromb Haemostas 1985; 53: 225-227
• 14 Von Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol (Basle) 1957; 17: 237-246
• 15 Cameron JS. Platelets in glomerular disease. Ann Rev Med 1984; 35: 175-180
• 16 Colwell JA, Halushka PV. Platelet function in diabetes mellitus. Br J Haematol 1980; 44: 521-526
• 17 Turney JH, Williams LC, Fewell MR, Parsons V, Weston MJ. Platelet protection and heparin sparing with prostacyclin during regular dialysis therapy. Lancet 1980; 2: 219-222
• 18 Greer IA, Walker JJ, McLaren M, Calder AA, Forbes CD. A comparative study of the effects of adrenoreceptor antagonists on platelet aggregation and thromboxane generation. Thromb Haemostas 1985; 54: 480-484
• 19 Onoda JM, Sloane BF, Honn KV. Antithrombogenic effects of calcium channel blockers: synergism with prostacyclin and thromboxane synthetase inhibitors. Thromb Res 1984; 34: 367-378
• 20 Doyle VM, Ruegg UT. Lack of evidence for voltage operated calcium channels on platelets. Biochem Biophys Res Commun 1985; 12: 161-167
• 21 Takahara K, Kuroiwa A, Matshushima T, Nakashima Y, Takasugi M. Effects of nifedipine on platelet function. Am Heart J 1985; 109: 4-8
• 22 Meade TW, Vickers MV, Thompson SG, Seghatchian MJ. The effect of physiological levels of fibrinogen on platelet aggregation. Thromb Res 1985; 38: 527-534
• 23 Milani L, Merkel C, Canel F, Gasparotto ML, Gatta A. Relationship between plasma levels of factor VIII related antigen and reticulo-endothelial function in chronic uraemia. Clin Nephrol 1983; 20: 235-238
• 24 Brunner FP, Brynger H, Chantier C, Donckerwolke RA, Hathway RA, Jacobs C, Selwood NH, Wing AJ. Combined report on regular dialysis and transplantation in Europe. Proc Eur Dial Transplant Assoc 1978; 16: 28-29
• 25 Purkerson ML, Joist JH, Yates J, Valdes A, Morrison A, Klahr S. Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation. Proc Natl Acad Sci USA 1985; 82: 193-197
• 26 Janson PA, Jubilirer SJ, Weinstein MJ, Deykin D. Treatment of the bleeding tendency in uraemia with cryoprecipitate. N Engl J Med 1980; 303: 1318-1322
• 27 Mannucci PM, Remuzzi G, Pusineri F, Lombardi R, Valsecchi C, Mecca G. Deamino-8-d-arginine vasopressin shortens the bleeding time in uraemia. N Engl J Med 1983; 308: 8-12
• 28 Livio M, Mannucci PM, Vigano G, Mingardi G, Lombardi R, Mecca G, Remuzzi G. Conjugated oestrogens for the management of bleeding associated with renal failure. N Engl J Med 1986; 315: 731-735
• 29 Andrassy K, Ritz E. Uraemia as a cause of bleeding. Am J Nephrol 1985; 5: 313-319